Search
for
Sort by
Research 871–900 of 1000+
- Reporting on Adverse Clinical Events
- Safety and use of oral minoxidil in pediatric patients: a systematic review and meta-analysis
- Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review
- Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
- Androgenetic Alopecia From A to Z
- Noninvasive Hair Rejuvenation
- The use of cyclosporine in dermatology: Part I
- Topical bimatoprost for the treatment of eyebrow hypotrichosis.
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Alopecia Areata Following the Use of Belimumab in a Patient with Systemic Lupus Erythematosus and Arthritis Who Responded Well to Baricitinib: A Case Report
- Valproate: It's effects on hair
- Androgenetic Alopecia in Transgender and Gender Diverse Populations: A Review of Therapeutics
- Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study
- Attenuation of disease process following treatment with low-dose naltrexone in patients with frontal fibrosing alopecia and lichen planopilaris: A retrospective study
- Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia
- Botulinum Toxins in Medical and Cosmetic Dermatology
- Report: Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS.
- Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Outcomes of Androgenetic Alopecia Treated with Dutasteride Mesotherapy: A Case Series
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Systemic Minoxidil Accidental Exposure in a Paediatric Population: A Case Series Study of Cutaneous and Systemic Side Effects
- [Translated article] High-dose Oral Minoxidil for the Treatment of Androgenetic Alopecia